MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4968 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-30 (informa.com)
Medtronic Presents Data To Boost Hugo's Odds Of Getting FDA Nod
Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.
Read more
2025-04-19 (investorshangout.com)
Medtronic Expands Diabetes Management with Simplera Sync™ Sensor - Investors Hangout
Medtronic announces FDA approval for the Simplera Sync™ sensor, enhancing the MiniMed™ 780G system and expanding diabetes management options for users.
Read more
2025-04-04 (beckersspine.com)
Medtech leadership moves in Q1: Stryker, Medtronic and more - Becker's Spine Review
Several spine and orthopedic medtech companies announced new leadership moves in the first quarter of 2025. 1. Medtronic appointed Thierry Piéton CFO. In the role, Mr. Piéton will be responsible for leading the Medtronic global finance organization and key support functions, including treasury, controller, tax, internal audit, investor relations, corporate strategy and business development. 2. […]
Read more